COMMUNIQUÉS West-GlobeNewswire

-
Vilacto Bio Introduces New LACTOACTIVE iTHER® Compound
10/09/2018 -
RespireRx Pharmaceuticals Inc. Secures Clinical and Commercial Supply of Dronabinol for Obstructive Sleep Apnea with the Signing of a Development and Supply Agreement with Noramco, Inc.
10/09/2018 -
CORRECTING and REPLACING – HempAmericana CEO Issues Letter on Shift to Commercial-Stage Operations
10/09/2018 -
Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Affirms Favorable U.S. Patent and Trademark Office Decision in CRISPR Interference
10/09/2018 -
HEXO acquires interest in 2M sq. ft. facility in Belleville, Ontario to create R&D and manufacturing centre of excellence
10/09/2018 -
HEXO acquiert une participation dans une installation de 2 M pi2 à Belleville (Ontario) afin de créer un centre d’excellence pour les coentreprises
10/09/2018 -
Medicare Brought Federal Involvement in Medicine, according to the Journal of American Physicians and Surgeons
10/09/2018 -
Ossur Hf : Transactions in relation to share buyback program
10/09/2018 -
Sanofi: Disclosure of trading in own shares
10/09/2018 -
Sanofi : Déclaration des transactions sur actions propres
10/09/2018 -
Direct Primary Care Popular with Patients and Physicians, according to the Journal of American Physicians and Surgeons
10/09/2018 -
Nova Leap Health Corp. to Participate in the Second Annual RAI$E on the West Coast Small-Cap Investing Conference
10/09/2018 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2018
10/09/2018 -
Wire-free, radar tumor localization quickly becoming the new standard of care across the US
10/09/2018 -
Medtronic Announces One-Month DAPT Clinical Study in the U.S. and Japan with Resolute Onyx DES in High Bleeding Risk Patients
10/09/2018 -
Cerner President Zane Burke to Step Down
10/09/2018 -
Transactions under Novozymes’ stock buyback program
10/09/2018 -
H1 To Incorporate Key Opinion Leader Data In Veeva CRM Platform
10/09/2018 -
CCAB and Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
10/09/2018
Pages